Literature DB >> 31539513

Sequential Versus Individual Saphenous Vein Grafting During Coronary Arterial Bypass Surgery.

Sung Jun Park1, Ho Jin Kim1, Joon Bum Kim1, Sung-Ho Jung1, Suk Jung Choo1, Jae Won Lee1, Cheol Hyun Chung2.   

Abstract

BACKGROUND: Although multiarterial grafting or bilateral mammary artery use is being increasingly emphasized for contemporary coronary artery bypass grafting (CABG) practice, saphenous vein graft (SVG) is still the most frequently used CABG conduit, and it accounts for 80% of all CABG conduits. Research focusing on modifiable surgical factors such as anastomosis technique, however, is scarce. This study aimed to compare clinical outcomes and graft patency according to anastomosis methods of vein grafting.
METHODS: From January 2005 through December 2016, patients who underwent CABG using SVG either by a sequential or an individual grafting technique were enrolled in this study. Graft patency was evaluated with coronary computed tomographic angiography. Propensity-score matching was used to compare the clinical outcomes and graft patency of these 2 grafting techniques to reduce treatment selection bias.
RESULTS: Overall 2515 eligible patients, 1,037 in the sequential SVG graft group (41.3%) and 1478 (58.8%) in the individual SVG graft group were enrolled. After propensity-score matching, 901 matched pairs of patients and 891 matched pairs of grafts were included in the final outcome analysis. There were no significant differences in unadjusted (P = .83) and adjusted overall mortality (hazard ratio [HR], 0.96; 95% confidence interval [CI], 0.79 to 1.17; P = .67). The composite outcome of death, nonfatal myocardial infarction, and repeat revascularization also did not significantly differ between the sequential SVG and the individual SVG groups for both before (P = .20) and after matching (HR, 0.91; 95% CI, 0.75 to 1.09; P = .30). The sequential grafts showed superior patency as compared with the individual grafts for both before (P = .015) and after adjustment (HR, 0.61; 95% CI, 0.45 to 0.82; P < .001).
CONCLUSIONS: The sequential grafting technique of SVG showed fairly acceptable safety and efficacy with superior long-term graft patency than individual grafts. Sequential SVG grafts perhaps can be a reasonable option as a second graft in CABG in some clinical situations.
Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31539513     DOI: 10.1016/j.athoracsur.2019.07.094

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Coronary Artery Bypass: Review of Surgical Techniques and Impact on Long-Term Revascularization Outcomes.

Authors:  Brian McNichols; John R Spratt; Jerin George; Scott Rizzi; Eddie W Manning; Ki Park
Journal:  Cardiol Ther       Date:  2021-01-30

2.  No-Touch Sequential Saphenous Venous Harvesting Technique in Off-Pump Bypass Surgery: A Retrospective Study.

Authors:  Xuejian Hou; Kui Zhang; Taoshuai Liu; Yang Li; Yang Zhao; Bangrong Song; Zhuhui Huang; Jubing Zheng; Ran Dong
Journal:  Front Cardiovasc Med       Date:  2022-01-24

3.  Patency and adverse outcomes of sequential vs. individual saphenous vein grafts in coronary artery bypass: A meta-analysis.

Authors:  He Jiao; Jinghui Li; Yunpeng Bai; Zhigang Guo
Journal:  Front Cardiovasc Med       Date:  2022-07-22

4.  Individual Versus Sequential Saphenous Vein Grafts for on-Pump Coronary Artery Bypass Grafting - Does Smaller Coronaries in Indians Affect Graft Choice? - A Mid-Term Patency Comparison Study.

Authors:  Manoj M Joshi; Saptarshi Paul; Krishnarao N Bhosle; Suraj W Nagre; Hrishikesh Parashi; Manish Jadhao; Kunal Rawekar; Vignesh Ravikumar; Vishal Sawkar; Joshua A Selwyn
Journal:  J Saudi Heart Assoc       Date:  2020-12-18

5.  The patency of graft and anastomoses in sequential and individual coronary artery bypass grafting: A meta-analysis.

Authors:  Yongxing Li; Baotang Liu; Caifei Li; YunChen Yu; Xiaobo Liu; Lei Li; Zijun Li; Chenxi Duan; Sheng Luo; Wenming Hou
Journal:  Anatol J Cardiol       Date:  2020-10       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.